Hvsen Biotechnology Co., Ltd. (300871.SZ) SHZ

20.68

+0.38(+1.87%)

Updated at September 26 03:04PM

Currency In CNY

Valuation

Market Cap1.67B
Enterprise Value2.21B
P/E Ratio25.63
PEG Ratio0.11
Price/Sales Ratio2.63
Price/Book Ratio1.85
Enterprise/Revenue2.69
Enterprise/EBITDA21.1

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.11

Management Effectiveness

Return On Assets0.05
Return On Equity0.09

Income Statement

Revenue1.2B
Revenue/Share8.59
Gross Profit196.06M
EBITDA126.98M
Net Income-20.16M
Diluted EPS-0.12

Balance Sheet

Total Cash514.18M
Total Cash/Share2.79
Total Debt330.42M
Total Debt/Equity0.16
Current Ratio1.57
Book Value Per Share11.19

Price History

52-Week Change95.09
52-Week High38.89
52-Week Low8.8
Moving Average 50 Days22.52
Moving Average 200 Days18.75

Statistics

Average Volume11.88M
Shares Outstanding201.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.21
Trailing Annual Dividend Yield1
Payout Ratio0.25
Last Split Factor3:2
Last Split DateMay 10, 2021